Yes, TMS can help people who are still going to work and keeping up appearances, as long as what they are living with is major depressive disorder that has not improved enough with antidepressants. TMS is FDA-cleared for major depression, not for a level of functioning, so the question is your diagnosis and treatment history, not whether you still make it to the office. If your symptoms are better described as persistent depressive disorder (dysthymia) without a major depressive episode, TMS would be off-label and has not been established for that condition.
Coverage is the harder part. Insurers usually want documented severity on a standardized scale, and some limit coverage to moderate-to-severe or severe depression. People who look "fine" from the outside are sometimes surprised by how high their scores are once they answer honestly.
What "high-functioning depression" usually means
"High-functioning depression" is not a formal diagnosis. It is a popular phrase for living with persistent low mood, exhaustion or emptiness while still meeting deadlines and showing up for others. A 2025 commentary in BJPsych Bulletin describes it as distress that often goes unnoticed or misattributed because outward functioning is preserved, which can delay diagnosis and increase the risk of progressing to major depression and suicidality. The site's page on high-functioning depression covers the everyday signs.
In clinical terms, the phrase can cover very different things:
- Major depressive disorder that you are pushing through, often at a high cost in sleep, relationships and health.
- Persistent depressive disorder (formerly dysthymia): a long-lasting, usually milder depression that can feel like "just who I am".
- "Double depression": a major depressive episode on top of long-standing persistent depressive disorder.
- Residual symptoms after partial improvement on an antidepressant.
- Burnout, grief, a medical problem or another condition that overlaps with depression; see the site's article on burnout vs depression.
Which of these fits you shapes whether TMS is even on the table, which is why a careful psychiatric evaluation comes first.
How you feel vs what TMS criteria look at
The gap between lived experience and paperwork is where many high-functioning people get stuck. The table below sets the two side by side.
| What you might be experiencing | What the FDA label and insurers typically look at |
|---|---|
| "I get through the day, but everything takes double the effort." | A diagnosis of major depressive disorder, current episode |
| "I have tried a couple of medications; they took the edge off but I am not myself." | Lack of satisfactory improvement from antidepressant medication in the current episode; many plans count trials by dose and duration |
| "The side effects made it impossible to keep taking them." | Documented intolerance, which several insurers count as a failed trial |
| "Nobody at work would guess." | Severity measured on a validated scale such as the PHQ-9, BDI, HAM-D or MADRS |
| "I have been in therapy for a while." | Some payers, including Medicare in New York and Cigna, require an adequate psychotherapy trial |
These criteria come from the FDA-cleared device indications and published insurer policies. Medication-trial requirements differ between plans: Medicare's local policy in New York and Optum also accept intolerance, Aetna asks adults for two antidepressants from different classes plus an augmentation trial, each for at least 8 weeks, and Cigna counts a trial after at least four weeks at an adequate dose. Our guide to how many antidepressants you need to try before TMS is covered goes plan by plan.
Severity, honesty and the scale on paper
Aetna's policy requires a psychiatrist's diagnosis of severe major depressive disorder documented with standardized rating scales, while Cigna's covers moderate-to-severe major depression. Optum asks for a documented baseline score on a validated scale and lists the diagnosis codes F32.2 and F33.2 as covered.
For high-functioning people, two things are true at once. First, coping well on the outside does not lower your score if you answer the questions about sleep, energy, concentration, guilt and enjoyment honestly; many people discover they have been minimizing for years. Second, scores should never be inflated to qualify. If your honest scores fall in a milder range, that is useful information, and it may point toward other treatments first. Our guide to TMS insurance coverage in New York explains the process.
A practical tip: before your evaluation, keep brief notes for a week or two. Write down when you woke, how much effort the morning took, what you skipped or postponed, and how you felt in the evening. High-functioning people tend to describe their best moments in appointments; notes capture the ordinary days, which are what the questionnaires are really asking about.
Depression also affects thinking. A meta-analysis of studies using a standard test battery found moderate deficits in executive function, memory and attention in people with depression, and some deficits in executive function and attention persisted after mood improved. If you have been compensating for slower thinking with longer hours, that is worth telling your psychiatrist.
If it is persistent depressive disorder (dysthymia)
Every FDA clearance for TMS in depression is for major depressive disorder, and the landmark trials enrolled people with major depression. TMS for persistent depressive disorder alone is therefore off-label, and the evidence for it is limited. Insurers that list covered diagnosis codes, such as Optum, list major depression codes.
That does not close the door for everyone with long-standing symptoms. Many people with persistent depressive disorder also have periods that meet criteria for a major depressive episode ("double depression"), and in that case the major depression may qualify. A psychiatrist can sort out which applies and what that means for treatment.
What TMS can realistically offer
People who are used to pushing through often hope for a clean reset. It helps to know what the evidence actually shows. In sham-controlled trials, the difference in remission between real and sham TMS is typically about 9 to 18 percentage points, and people treated with sham also improve noticeably, so TMS is a meaningful option rather than a guaranteed one. Results in everyday clinics, which are open-label and not directly comparable, tend to look better than trial figures; the 2012 study of 307 patients across 42 U.S. practices reported clinician-rated remission of 37.1% and patient-reported PHQ-9 remission of 28.7%.
Benefit does not always last indefinitely. Studies suggest that roughly half to about 6 in 10 people who respond are still doing well a year later, and maintenance sessions are usually not covered: Aetna and Cigna, for example, treat maintenance TMS as experimental or not medically necessary. That is one reason a relapse-prevention plan, including therapy and attention to sleep and workload, matters for people with demanding lives; see life after TMS: building a relapse-prevention plan.
What many high-functioning people value most is not a dramatic change but the return of ease: getting through the day without the constant extra effort. Tracking a scale before, during and after the course is the best way to see whether that is happening.
Fitting TMS around a full-time job
The practical worry for working people is the schedule. A standard course is 5 sessions a week for 6 weeks, then a 3-week taper, for 36 sessions in total. Each standard session can take as little as about 19 minutes on current devices, and theta-burst sessions, where used, last about 3 minutes, plus time to set up. Many people schedule sessions before work, at lunch or at the end of the day; our guides to working and driving during a TMS course and fitting daily sessions into a Brooklyn week have practical tips.
What about accelerated TMS?
Accelerated protocols pack many sessions into fewer days. SAINT, for example, is 10 sessions a day for 5 days, and other accelerated schedules have since been FDA-cleared. That can be appealing if you could take a week off rather than commuting daily for six weeks. The catch is coverage: Aetna, Cigna and Optum currently classify accelerated protocols as experimental or unproven, and Cigna and Optum say the same of theta-burst protocols. See is accelerated TMS covered by insurance? before planning around it.
When something else may come first
TMS is not the default answer to feeling stuck. If you have had only one short medication trial, have never had structured therapy, or your symptoms are milder, optimizing those treatments may make more sense first. Guidelines generally place TMS after medication and psychotherapy have not worked well enough, though CANMAT 2023 says it can be a first-choice treatment when medication side effects are a concern. Integrative steps such as sleep, movement and nutrition can support any plan, which we cover in supporting your TMS course with sleep, movement and nutrition.
And high-functioning does not mean low-risk. People who look capable are sometimes the last to be asked how they are really doing.
If you are thinking about suicide or are in crisis, call or text 988 (the 988 Suicide & Crisis Lifeline) or go to the nearest emergency room.
Next steps
- Take the PHQ-9 honestly and note your score; see signs your depression treatment is not working for how to read it.
- List every antidepressant you have tried, with doses, durations and side effects.
- Ask your psychiatrist whether your symptoms fit major depression, persistent depressive disorder or both.
- Go through the TMS candidate checklist together.
You can also explore the full TMS guide or read about TMS treatment for depression.
Sources
- 510(k) K160703 (NeuroStar TMS Therapy System). U.S. FDA, 2016. accessdata.fda.gov
- 510(k) K122288 (BrainsWay Deep TMS System). U.S. FDA, 2013. accessdata.fda.gov
- Transcranial Magnetic Stimulation and Cranial Electrical Stimulation (Clinical Policy Bulletin 0469). Aetna, 2026. aetna.com
- Transcranial Magnetic Stimulation (Coverage Policy EN0383). Evernorth Health Services (Cigna), 2026. a.static.cigna.com
- Behavioral Clinical Policy: Transcranial Magnetic Stimulation (BH803TMS112025). Optum Behavioral Health Solutions, 2026. providerexpress.com
- Transcranial Magnetic Stimulation (LCD L33398). CMS Medicare Coverage Database, 2026. cms.gov
- Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biological Psychiatry, 2007. pubmed.ncbi.nlm.nih.gov
- Daily left prefrontal transcranial magnetic stimulation therapy for major depressive disorder: a sham-controlled randomized trial. Archives of General Psychiatry, 2010. pubmed.ncbi.nlm.nih.gov
- K231926 510(k) Summary – NeuroStar Advanced Therapy System. U.S. FDA, 2024. accessdata.fda.gov
- K173620 510(k) Summary – MagVita TMS Therapy System w/Theta Burst Stimulation. U.S. FDA, 2018. accessdata.fda.gov
- K220177 510(k) Summary – Magnus Neuromodulation System with SAINT Technology. U.S. FDA, 2022. accessdata.fda.gov
- 510(k) Premarket Notification K260189 and 510(k) summary (MagVenture Accelerated TMS). U.S. FDA, 2026. accessdata.fda.gov
- Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults. Canadian Journal of Psychiatry, 2024. pmc.ncbi.nlm.nih.gov
- Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice. Depression and Anxiety, 2012. pubmed.ncbi.nlm.nih.gov
- Durability of antidepressant response to repetitive transcranial magnetic stimulation: Systematic review and meta-analysis. Brain Stimulation, 2019. pubmed.ncbi.nlm.nih.gov
- High-functioning depression: a hidden burden demanding clinical recognition. BJPsych Bulletin, 2025. pubmed.ncbi.nlm.nih.gov
- Cognitive impairment in depression: a systematic review and meta-analysis. Psychological Medicine, 2014. pubmed.ncbi.nlm.nih.gov
- Billing and Coding: Transcranial Magnetic Stimulation (A57528, version 5). Wellpoint Federal, CMS Medicare Coverage Database, 2026. cms.gov
FAQs
Can I get TMS if I have never missed a day of work?
Possibly. TMS eligibility depends on a diagnosis of major depression and how it has responded to treatment, not on whether you are still working. Insurers do look at severity, measured with a standardized scale.
Is TMS used for dysthymia?
Not as an established treatment. FDA clearances and the main trials are for major depressive disorder, so TMS for persistent depressive disorder alone would be off-label. If you also have a current major depressive episode, that may change things.
Will my employer find out I am having TMS?
Your health information is private, and you do not have to tell your employer what treatment you are having. If you need schedule flexibility, many people simply ask for recurring medical appointments.
Can I do TMS sessions before work?
Often, yes. Standard sessions can be short on current devices, and many clinics schedule early or late appointments. Ask any clinic about its hours, since these vary.
Does high-functioning depression get better on its own?
Sometimes symptoms ease, but persistent depression can also deepen into a major depressive episode. It is worth an evaluation rather than waiting it out.
